![]() Imago BioSciences Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases. | ![]() Merck Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. | ![]() Incyte Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. | ![]() Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. | ![]() Constellation Pharmaceuticals Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel therapeutics that address serious unmet medical needs in patients with cancers. | ![]() Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | ||
Founding Date | Founding Date 2012 | Founding Date 1891 | Founding Date 1991 | Founding Date 2007 | Founding Date 2008 | Founding Date 1887 | Founding Date 1997 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||||
Locations | Locations Rahway, US HQ | Locations Rahway, US HQ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE Santa Cruz De La Sierra, BO see more | Locations Wilmington, US HQ Wien, AT Pointe Claire, CA Frederiksberg, DK Boulogne Billancourt, FR München, DE Milano, IT see more | Locations Cambridge, US HQ | Locations Cambridge, US HQ Boston, US | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Planegg, DE HQ |
Employees | Employees 2759% increase | Employees 73,0004% increase | Employees 1,4567% increase | Employees 20364% increase | Employees 474% decrease | Employees 34,100 | Employees 13 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 294.7 b | Valuation ($) 14.2 b | Valuation ($) 250.8 m | Valuation ($) N/A | Valuation ($) 97.8 b | Valuation ($) 74 m |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $65b (FY, 2025) | Revenue (est.) $5.1b (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) €336k (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $16.4b (FY, 2025) | Cost of goods $372.1m (FY, 2025) | Cost of goods $10.5m (FY, 2021) | Cost of goods N/A | Cost of goods $13.9b (FY, 2025) | Cost of goods €84k (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $48.6b (FY, 2025) | Gross profit $4.8b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $34.3b (FY, 2025) | Gross profit €261k (FY, 2024) |
Net income | Net income ($42.3m) (FY, 2021) | Net income $18.3b (FY, 2025) | Net income $1.3b (FY, 2025) | Net income ($251.1m) (FY, 2021) | Net income ($35.4m) (FY, 2017) | Net income $7.1b (FY, 2025) | Net income (€8.3m) (FY, 2024) |
Funding | |||||||
Total funding raised | Total funding raised $ 146.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 51.5m | Total funding raised $ 403.6m | Total funding raised $ 15.5m | Total funding raised N/A |

Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health.
View company
Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.
View company
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View company
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel therapeutics that address serious unmet medical needs in patients with cancers.
View company